Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-16

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial

NCT02067065

Digestive System Diseases Colonoscopy Sedation

COMPLETED NA

Safety Study of Colonoscopy Under Sedation

NCT00930358

Colonoscopy Procedure

TERMINATED PHASE4

Propofol vs. Midazolam-based Balanced Propofol for Nonanesthesiologist Moderate Sedation in Colonoscopy

NCT01428882

Procedural Sedation

COMPLETED PHASE4

Explore the Clinical Application Value of Ciprofol in Painless Colonoscopy

NCT05294679

Induction of Anaesthesia

COMPLETED NA

Patient Satisfaction With Propofol for Out Patient Colonoscopy

NCT02937506

Colon Cancer IBS Polyps

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home.

This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Safety Issues

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propofol

Using \> 200 mg of propofol sedation colonoscopy is performed. 90-120 minutes after colonoscopy subjects go home. Within 1 week patients will be asked about their condition and satisfaction for colonoscopy.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* subjects who drive home by theirselves after colonoscopy using propofol sedation (\>200 mg)

Exclusion Criteria

* Subjects who received emergency procedures
* less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight \>100 kg) allergic to the drugs used or its components (soybeans or eggs).

Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No